Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · IEX Real-Time Price · USD
+0.24 (0.69%)
At close: Jun 17, 2024, 4:00 PM
+1.09 (3.12%)
Pre-market: Jun 18, 2024, 8:15 AM EDT

Celldex Therapeutics Statistics

Total Valuation

CLDX has a market cap or net worth of $2.30 billion. The enterprise value is $1.48 billion.

Market Cap 2.30B
Enterprise Value 1.48B

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, after market close.

Earnings Date Aug 6, 2024
Ex-Dividend Date n/a

Share Statistics

CLDX has 65.91 million shares outstanding. The number of shares has increased by 24.69% in one year.

Shares Outstanding 65.91M
Shares Change (YoY) +24.69%
Shares Change (QoQ) +13.07%
Owned by Insiders (%) 0.26%
Owned by Institutions (%) 107.45%
Float 65.73M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 378.94
Forward PS 792.64
PB Ratio 2.74
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 243.61
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 31.77, with a Debt / Equity ratio of 0.00.

Current Ratio 31.77
Quick Ratio 31.44
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -32.30% and return on invested capital (ROIC) is -19.35%.

Return on Equity (ROE) -32.30%
Return on Assets (ROA) -30.30%
Return on Capital (ROIC) -19.35%
Revenue Per Employee $37,950
Profits Per Employee -$905,475
Employee Count 160
Asset Turnover 0.01
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -5.19% in the last 52 weeks. The beta is 1.47, so CLDX's price volatility has been higher than the market average.

Beta (1Y) 1.47
52-Week Price Change -5.19%
50-Day Moving Average 37.72
200-Day Moving Average 35.11
Relative Strength Index (RSI) 43.68
Average Volume (30 Days) 646,709

Short Selling Information

The latest short interest is 6.27 million, so 9.51% of the outstanding shares have been sold short.

Short Interest 6.27M
Short Previous Month 6.62M
Short % of Shares Out 9.51%
Short % of Float 9.53%
Short Ratio (days to cover) 11.38

Income Statement

In the last 12 months, CLDX had revenue of $6.07 million and -$144.88 million in losses. Loss per share was -$2.86.

Revenue 6.07M
Gross Profit 6.07M
Operating Income -162.68M
Pretax Income -144.88M
Net Income -144.88M
EBITDA -141.82M
EBIT -144.88M
Loss Per Share -$2.86
Full Income Statement

Balance Sheet

The company has $823.85 million in cash and $2.11 million in debt, giving a net cash position of $821.73 million or $12.47 per share.

Cash & Cash Equivalents 823.85M
Total Debt 2.11M
Net Cash 821.73M
Net Cash Per Share $12.47
Equity / Book Value 838.61M
Book Value Per Share 12.72
Working Capital 809.03M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$119.36 million and capital expenditures -$1.58 million, giving a free cash flow of -$120.94 million.

Operating Cash Flow -119.36M
Capital Expenditures -1.58M
Free Cash Flow -120.94M
FCF Per Share -$2.05
Full Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -2,679.17% and -2,385.97%.

Gross Margin 100.00%
Operating Margin -2,679.17%
Pretax Margin -2,385.97%
Profit Margin -2,385.97%
EBITDA Margin -2,335.62%
EBIT Margin -2,385.97%
FCF Margin -1,991.72%

Dividends & Yields

CLDX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -24.69%
Shareholder Yield -24.69%
Earnings Yield -6.30%
FCF Yield -5.26%
Dividend Details

Analyst Forecast

The average price target for CLDX is $66.00, which is 89.06% higher than the current price. The consensus rating is "Buy".

Price Target $66.00
Price Target Difference 89.06%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 126.94%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on February 11, 2019. It was a reverse split with a ratio of 1:15.

Last Split Date Feb 11, 2019
Split Type Reverse
Split Ratio 1:15


CLDX has an Altman Z-Score of 43.93 and a Piotroski F-Score of 4.

Altman Z-Score 43.93
Piotroski F-Score 4